Shares of 22nd Century Group's Cannabis Research Co. Slightly Up On $40M Registered Direct Offering With Cowen and Company

Plant-based biotech company 22nd Century Group, Inc. (NYSE AMEX: XXII) announced Monday it will raise $40 million via a registered direct offering with one institutional investor.

The Buffalo, -based company involved in and hemp agreed to sell 10 million common shares with a price of $4.00 per share. The only placement agent for the offering was Cowen and Company, LLC, while The Special Equities Group, a division of Dawson James Securities Inc. is serving as financial advisor …

Full story available on Benzinga.com

More Shares of 22nd Century Group's Cannabis Research Co. Slightly Up On $40M Registered Direct Offering With Cowen and Company